000 03797nam a22004815i 4500
001 978-3-540-71279-4
003 DE-He213
005 20161121230847.0
007 cr nn 008mamaa
008 100301s2008 gw | s |||| 0|eng d
020 _a9783540712794
_9978-3-540-71279-4
024 7 _a10.1007/978-3-540-71279-4
_2doi
050 4 _aRC254-282
072 7 _aMJCL
_2bicssc
072 7 _aMED062000
_2bisacsh
082 0 4 _a616.994
_223
100 1 _aRiess, Hanno.
_eauthor.
245 1 0 _aPancreatic Cancer
_h[electronic resource] /
_cby Hanno Riess, Andrea Goerke, Helmut Oettle.
264 1 _aBerlin, Heidelberg :
_bSpringer Berlin Heidelberg,
_c2008.
300 _aXII, 186 p. 48 illus., 12 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aRecent Results in Cancer Research,
_x0080-0015 ;
_v177
505 0 _aPancreatic Cancer: Step by Step Forward -- Pancreatic Cancer: Step by Step Forward -- Diagnosis -- CT and MR Imaging of Pancreatic Cancer -- Nuclear Medical Methods for the Diagnosis of Pancreatic Cancer: Positron Emission Tomography -- Therapy and Monitoring of Disease -- Surgical Techniques for Resectable Pancreatic Cancer -- Postoperative Staging of Pancreatic Cancer -- Adjuvant Therapy in Patients with Pancreatic Cancer -- First-Line Chemotherapy in Advanced Pancreatic Cancer -- Second-Line Chemotherapy in Advanced Pancreatic Cancer -- Neoadjuvant and Adjuvant Strategies for Chemoradiation -- Primary Advanced Unresectable Pancreatic Cancer -- Brachytherapy of Liver Metastases -- Detection of Disease Recurrence and Monitoring of Therapy -- Surgical Palliation of Advanced Pancreatic Cancer -- New Treatment Strategies and Outlook -- Antiangiogenic Strategies in Pancreatic Cancer -- Targeted Therapy of the Epidermal Growth Factor Receptor in the Treatment of Pancreatic Cancer -- Antisense Therapeutics for Tumor Treatment: The TGF-beta2 Inhibitor AP 12009 in Clinical Development Against Malignant Tumors -- NF-? B as a Molecular Target in the Therapy of Pancreatic Carcinoma -- Immunotherapeutic Approaches in Pancreatic Cancer -- Src Kinase and Pancreatic Cancer.
520 _aAlthough pancreatic cancer is one of the most serious forms of cancers, the outlook for patients could be improved. The lack of clinical symptoms of early, surgically removable disease most often limits curative treatment options. The aggressive tumor cell biology, leading to a locally advanced nature of the disease and to early metastases, allows curative resection in only 20% of patients at the time of diagnosis. This book gives insight into the current understanding of the management of pancreatic cancer and considers recent findings in cancer research. It provides answers to questions of how to know when cancer is respectable, how to proceed when the diagnosis comes too late for a curative approach, and how to assess different study results. Moreover, it highlights new upcoming therapeutic options and experimental approaches, which might further improve the future prospects for patients with pancreatic adenocarcinoma.
650 0 _aMedicine.
650 0 _aGastroenterology.
650 0 _aOncology.
650 1 4 _aMedicine & Public Health.
650 2 4 _aOncology.
650 2 4 _aGastroenterology.
700 1 _aGoerke, Andrea.
_eauthor.
700 1 _aOettle, Helmut.
_eauthor.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9783540712664
830 0 _aRecent Results in Cancer Research,
_x0080-0015 ;
_v177
856 4 0 _uhttp://dx.doi.org/10.1007/978-3-540-71279-4
912 _aZDB-2-SME
950 _aMedicine (Springer-11650)
999 _c505049
_d505049